Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 1/2
This trial looked at a treatment called T cell receptor . It was for people with acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS).
The trial was open for people to join between 2015 and 2018. The team analysed the results in 2019.
Recruitment start: 1 July 2015
Recruitment end: 15 May 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Emma Morris
Cell Therapy Catapult
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 21 Sept 2023
CRUK internal database number: 12641
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
